We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with type 2 diabetes may have a new treatment ...

European Union (EU) regulators announced today that they will study whether the cardiovascular, neurological, and psychiatric risks of using bromocriptine to inhibit lactation in women after ...

Bromocriptine is a sympatholytic D2-dopamine agonist that has been approved for the treatment of type 2 diabetes. Based on animal and human studies, timed bromocriptine administration within 2 h of ...

Review the side-effects of Bromocriptine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Please provide your email address to receive an email when new articles are posted on . Quick-release bromocriptine is a new formulation of bromocriptine mesylate that the FDA approved in May 2009 for ...

Bromocriptine activates post-synaptic dopamine receptors. The dopaminergic neurons in the tuberoinfundibular process modulate the secretion of prolactin from the anterior pituitary by secreting a ...

In obese, insulin-resistant animals, treatment with the dopamine D2 receptor (D2R) agonist bromocriptine causes reversion to a lean, insulin-sensitive state. Kok and colleagues, therefore, studied the ...

Bromocriptine (Bromocriptine Mesylate) is a dopamine agonist, prescribed for Parkinson’s disease either alone or with other medications. It is also used for galactorrhoea (abnormal milk production), ...

A 19-year-old man was admitted to an outpatient clinic because of progressive visual impairment and homonymous hemianopsia for 2 years. Cerebral magnetic resonance imaging revealed a giant mass within ...

L’Agence nationale de sécurité du médicament et des produits de santé (ANSM) a demandé une réévaluation européenne du rapport bénéfice/risque des médicaments contenant de la bromocriptine (Parlodel® ...

Prolactinoma is the most frequent pituitary tumor histotype. Men generally have macroadenomas whereas women generally have microadenomas. The major objectives of treating prolactinomas are to suppress ...

Zydus Cadila is recalling over 14,800 bottles of Bromocriptine Mesylate capsules manufactured by Cadila Healthcare on account of out of specification results in the US market. According to information ...